JAK Inhibitor Shows Promise in Severe Type of Sclerosis
Study finds genetic basis long sought in disabling pansclerotic morphea, leading to effective tx
Source: medpagetoday.com
Stay updated with breaking news from Inflammatory Disease Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study finds genetic basis long sought in disabling pansclerotic morphea, leading to effective tx
LOS ANGELES, June 1 (Xinhua) -- Researchers at the U.S. National Institutes of Health (NIH) have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.